Your browser doesn't support javascript.
loading
Age-specific prevalence of IgG against measles/rubella and the impact of routine and supplementary immunization activities: A multistage random cluster sampling study with mathematical modelling.
Hachiya, Masahiko; Vynnycky, Emilia; Mori, Yoshio; Do, Hung Thai; Huynh, Mai Kim; Trinh, Long Hoang; Nguyen, Duy Duc; Tran, Nhu Anh Thi; Hoang, Thanh Tien; Hoang, Hai Hang Thi; Vo, Ngoc Dieu Thi; Le, Thieu Hoang; Ichimura, Yasunori; Miyano, Shinsuke; Okawa, Sumiyo; Thandar, Moe Moe; Yokobori, Yuta; Inoue, Yosuke; Mizoue, Tetsuya; Takeda, Makoto; Komada, Kenichi.
Afiliación
  • Hachiya M; Bureau of International Health Cooperation and World Health Organization Collaborating Center for Health Systems Development, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan. Electronic address: m-hachiya@it.ncgm.go.jp.
  • Vynnycky E; United Kingdom Health Security Agency, London, UK; London School of Hygiene & Tropical Medicine, London, UK.
  • Mori Y; Department of Virology 3 and World Health Organization Global Specialized Laboratory for Measles and Rubella, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
  • Do HT; Pasteur Institute in Nha Trang, Nha Trang City, Viet Nam.
  • Huynh MK; Microbiology and Immunology, Pasteur Institute in Nha Trang, Nha Trang City, Viet Nam.
  • Trinh LH; Microbiology and Immunology, Pasteur Institute in Nha Trang, Nha Trang City, Viet Nam.
  • Nguyen DD; Microbiology and Immunology, Pasteur Institute in Nha Trang, Nha Trang City, Viet Nam.
  • Tran NAT; Microbiology and Immunology, Pasteur Institute in Nha Trang, Nha Trang City, Viet Nam.
  • Hoang TT; Infectious Diseases Control and Prevention, Pasteur Institute in Nha Trang, Nha Trang City, Viet Nam.
  • Hoang HHT; Infectious Diseases Control and Prevention, Pasteur Institute in Nha Trang, Nha Trang City, Viet Nam.
  • Vo NDT; Infectious Diseases Control and Prevention, Pasteur Institute in Nha Trang, Nha Trang City, Viet Nam.
  • Le TH; Infectious Diseases Control and Prevention, Pasteur Institute in Nha Trang, Nha Trang City, Viet Nam.
  • Ichimura Y; Bureau of International Health Cooperation and World Health Organization Collaborating Center for Health Systems Development, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Miyano S; Bureau of International Health Cooperation and World Health Organization Collaborating Center for Health Systems Development, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Okawa S; Bureau of International Health Cooperation and World Health Organization Collaborating Center for Health Systems Development, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Thandar MM; Bureau of International Health Cooperation and World Health Organization Collaborating Center for Health Systems Development, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Yokobori Y; Bureau of International Health Cooperation and World Health Organization Collaborating Center for Health Systems Development, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Inoue Y; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Mizoue T; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Takeda M; Department of Virology 3 and World Health Organization Global Specialized Laboratory for Measles and Rubella, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
  • Komada K; Bureau of International Health Cooperation and World Health Organization Collaborating Center for Health Systems Development, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
Int J Infect Dis ; 144: 107053, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38641317
ABSTRACT

BACKGROUND:

Vietnam continues to have measles and rubella outbreaks following supplementary immunization activities (SIA) and routine immunization despite both having high reported coverage. To evaluate immunization activities, age-specific immunity against measles and rubella, and the number of averted Congenital Rubella Syndrome (CRS) cases, must be estimated.

METHODS:

Dried blood spots were collected from 2091 randomly selected individuals aged 1-39 years. Measles and rubella virus-specific immunoglobulin G (IgG) were measured by enzyme immunoassay. Results were considered positive at ≥120 mIU/mL for measles and ≥10 IU/mL for rubella. The number of CRS cases averted by immunization since 2014 were estimated using mathematical modelling.

RESULTS:

Overall IgG seroprevalence was 99.7% (95%CI 99.2-99.9) for measles and 83.6% (95%CI 79.3-87.1) for rubella. Rubella IgG seroprevalence was higher among age groups targeted in the SIA than in non-targeted young adults (95.4% [95%CI 92.9-97.0] vs 72.4% [95%CI 63.1-80.1]; P < 0.001). The estimated number of CRS cases averted in 2019 by immunization activities since 2014 ranged from 126 (95%CI 0-460) to 883 (95%CI 0-2271) depending on the assumed postvaccination reduction in the force of infection.

CONCLUSIONS:

The results suggest the SIA was effective, while young adults born before 1998 who remain unprotected for rubella require further vaccination.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rubéola (Sarampión Alemán) / Inmunoglobulina G / Sarampión / Anticuerpos Antivirales Idioma: En Revista: Int J Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rubéola (Sarampión Alemán) / Inmunoglobulina G / Sarampión / Anticuerpos Antivirales Idioma: En Revista: Int J Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2024 Tipo del documento: Article
...